Bristol Myers Squibb Co
NYSE · Healthcare · Pharmaceutical Preparations · Princeton, NJ
BMY chart
What traders are saying about $BMY
Latest postsBristol Myers Squibb Co news
- Bristol Myers Squibb (BMY) Stock Still Looks Reasonable Below Fair Value
Yahoo Finance ·
- Has Regeneron Stock Become A Different Bet?
trefis.com ·
- What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
Yahoo Finance ·
- AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
Yahoo Finance ·
- Bristol Myers Squibb Licenses In Anticancer Drug That Extends Progression-Free Survival, Why Investors Reacted Mutedly
NAI500 ·
- Bristol Myers Squibb’s Cancer Drug Just Doubled Survival Time Without Progression — Here’s Why It Matters
fool.com ·
- Bristol Myers Squibb confirms patient death in multiple sclerosis CAR T trial
BioXconomy ·
- What Does Bristol Myers Squibb (BMY) Zola Cel MS Trial Update Mean?
Yahoo Finance ·
- What Would A Biktarvy Slowdown Do To Gilead Stock?
trefis.com ·
- 3 Cheap Dividend Stocks I'd Buy Without Any Hesitation
fool.com ·
- Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?
Zacks Investment Research ·
- Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock
marketbeat.com ·
Bristol Myers Squibb Co key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $48.19B | $48.30B | $45.01B | $46.16B |
| Net income | $7.05B | -$8.95B | $8.03B | $6.33B |
| Diluted EPS | $3.46 | $-4.41 | $3.86 | $2.95 |
| Total assets (year end) | $90.04B | $92.60B | $95.16B | $96.82B |
| Cash and equivalents (year end) | $10.21B | $10.35B | $11.46B | $9.12B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 10-Q10-Q
- 8-K8-K
- 8-KCURRENT REPORT
- 10-Q10-Q
- 8-K8-K
- DEF 14ADEF 14A
- 10-K10-K
- 8-K8-K
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KFORM 8-K
- 8-KCURRENT REPORT
About Bristol Myers Squibb Co
- Ticker
- BMY (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Princeton, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 14272
Frequently asked questions
What exchange is Bristol Myers Squibb Co listed on?
Bristol Myers Squibb Co trades on the NYSE under the ticker symbol BMY.
What industry is Bristol Myers Squibb Co in?
Bristol Myers Squibb Co is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Bristol Myers Squibb Co headquartered?
Bristol Myers Squibb Co's business address on file with the SEC is in Princeton, NJ.
When does Bristol Myers Squibb Co's fiscal year end?
Bristol Myers Squibb Co's fiscal year ends on December 31.
How much revenue did Bristol Myers Squibb Co report?
Bristol Myers Squibb Co reported $48.19B in revenue for calendar year 2025, according to its SEC filings.